Tuesday, April 13, 2021
(WEST COVINA, CA) - Today, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) is recommending a pause in the use of the Johnson & Johnson COVID-19 vaccine out of an abundance of caution. This recommendation comes after six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the Johnson & Johnson vaccine. This pause will be in place until the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) completes a thorough review of the reported cases.
East Valley’s medical leadership team is closely monitoring the situation and in alignment with the CDC’s and FDA’s recommendation. The safety and health of our patients & community members are of our utmost priority. East Valley Community Health Center has paused administration of the Johnson & Johnson vaccine from all its vaccination Point of Distribution (POD) sites until further notice from the CDC is received. East Valley’s vaccination Point of Distribution (POD) sites will continue to administer the Moderna vaccine and we encourage our patients & community to continue scheduling their COVID-19 vaccination appointment. Visit www.my turn.ca.gov for guidance on scheduling your vaccination appointment.
Link to CDC Media Release: www.cdc.gov/media/releases/2021/s0413-JJ-vaccine.html
How rare is this side effect?
As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been administered in the U.S. The CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the Johnson & Johnson vaccine. The 6 cases occurred among women between the ages of 18 and 48, and symptoms occurred 6 to 13 days after receiving the Johnson & Johnson vaccine.
I received the Johnson & Johnson vaccine. What should I do?
Any individual who has received the Johnson & Johnson vaccine in the last three weeks should look for any symptoms of these unusual clots, including severe headaches, abdominal or leg pain, and shortness of breath, and seek medical care if symptoms develop.
For more information, contact Claudia Rodríguez Soto, Director of Communications and Development, on her mobile: (626) 774-4118. You can also email her at the following: email@example.com